U. S. Department of Health and Human Services, Food and Drug Administration: Innovation or stagnation; challenge and opportunity on the critical path to new medical products.2004 (http://www.fda.gov/oc/initiatives/criticalpath/whitepaper.html)
U. S. Department of Health and Human Services, Food and Drug Administration: Innovation or stagnation; critical path opportunities report.2006 (http://www.fda.gov/oc/initiatives/criticalpath/reports/opp_report.pdf)
U. S. Department of Health and Human Services, Food and Drug Administration: Guidance for industry; pharmacogenomic data submissions.2005 (http://www.fda.gov/cder/guidance/6400fnl.pdf)
U. S. Department of Health and Human Services, Food and Drug Administration: Microarray quality control (MAQC) project (http://www.fda.gov/nctr/science/centers/toxicoinformatics/maqc/)